Atrial Fibrillation Clinical Trials in New Orleans, Louisiana

7 studies are recruiting for atrial fibrillation in New Orleans, Louisiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. The Fourth Left Atrial Appendage Occlusion Study

   LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ochsner Clinic Foundation, New Orleans, Louisiana

   Locations

   150 in total

   Run by

   Hamilton Health Sciences Corporation

   See if you can join NCT05963698 on ClinicalTrials.gov

2. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

   The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Ochsner Clinic, New Orleans, Louisiana

   Locations

   106 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT04045665 on ClinicalTrials.gov

3. Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

   The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).

   Stage

   Not phased

   Ages

   18 to 75

   Site

   East Jefferson General Hospital, New Orleans, Louisiana

   Locations

   3 in total

   Run by

   Tulane University

   See if you can join NCT04814420 on ClinicalTrials.gov

4. Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

   The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize t…

   Stage

   Not phased

   Ages

   40 to 120

   Site

   East Jefferson General Hospital, New Orleans, Louisiana

   Locations

   3 in total

   Run by

   Tulane University

   See if you can join NCT05014802 on ClinicalTrials.gov

5. Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

   To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

   Stage

   Not phased

   Ages

   18 to 79

   Site

   Tulane University School of Medicine, New Orleans, Louisiana

   Run by

   Tulane University School of Medicine

   See if you can join NCT04703166 on ClinicalTrials.gov

6. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

   Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Ochsner Medical Center - Main Campus, New Orleans, Louisiana

   Locations

   187 in total

   Run by

   Yale University

   See if you can join NCT03907046 on ClinicalTrials.gov

7. The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study

   The aim of the Correlation Of CoAGulation-Atrial Fibrillation (COAG-AF) study is to prove that an increase in pro-thrombotic biomarkers in AF is associated with an increase in AF burden. Secondary objectives of the study are the following: * To investigate the impact of catheter ablation on serum p…

   Stage

   Not phased

   Ages

   18 to 120

   Site

   East Jefferson General Hospital, New Orleans, Louisiana

   Locations

   3 in total

   Run by

   Tulane University

   See if you can join NCT04947657 on ClinicalTrials.gov